Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)
Rani Therapeutics Holdings' Construction in Progress came in at $3.5 million for Q4 2021, unchanged from $3.5 million a year earlier.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021) Analysis & Trends
- Going back by year, Construction in Progress was $3.5 million in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Rani Therapeutics Holdings | 113.26 Mn | -6.31 Mn | - | - |
API Access
Rani Therapeutics Holdings Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();